Biotype
#read

BIOTYPE enters into partnership with Urteste S.A.

BIOTYPE starts a strategic partnership with the cancer screening company Urteste in the field of molecular diagnostics.
07/08/2025

The Dresden-based company will produce five batches of Urteste's Panuri and Panuri Control Kits. These will be used for analytical evaluations, validation tests and a planned clinical trial. The co-operation marks an important step towards bringing innovative diagnostics into clinical application more quickly. BIOTYPE is focussing on high-quality and scalable production solutions to support primary tests in a crucial development phase. Together, the two partners aim to advance precision diagnostics and provide new impetus for the international IVD industry.

Press release "BIOTYPE" from 07/08/2025

The above texts, or parts thereof, were automatically translated from the original language text using a translation system (DeepL API).
Despite careful machine processing, translation errors cannot be ruled out.

Click here to access the original content